KH001 for Tooth Sensitivity
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment KH001 for tooth sensitivity?
Is KH001 safe for human use?
How does the drug KH001 for tooth sensitivity differ from other treatments?
KH001 is unique because it may involve components like calcium hydroxide, which has been shown to be more consistently effective in reducing tooth sensitivity compared to other agents like potassium nitrate. This suggests that KH001 could offer a more reliable reduction in sensitivity to various stimuli, such as hot, cold, and mechanical irritation.1112131415
Research Team
Hatice Hasturk
Principal Investigator
ADA Forsyth
Eligibility Criteria
This trial is for individuals experiencing tooth sensitivity due to hypersensitive dentin. Specific eligibility criteria are not provided, but typically participants must meet certain health standards and not have conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive three topical applications of KH001 or placebo
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- KH001
Find a Clinic Near You
Who Is Running the Clinical Trial?
HysensBio Co., Ltd
Lead Sponsor
The Forsyth Institute
Collaborator